Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone + Dapagliflozin in Type 1 Diabetes
NCT03878459Phase 4Active, not recruiting
- Sponsor
- UT Health San Antonio
- Start
- Aug 2019
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of pioglitazone in type 1 diabetes mellitus (T1D), sponsored by UT Health San Antonio. Started Aug 2019; status: active, not recruiting.
02
Drugs
pioglitazone
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03878459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03878459.